Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 5.79M | 100% | $ 5.79M |
3/31/2025 | $ 7.56M | 100% | $ 7.56M |
12/31/2024 | $ 7.02M | 100% | $ 7.02M |
9/30/2024 | $ 9.98M | 100% | $ 9.98M |
6/30/2024 | $ 8.3M | 100% | $ 8.3M |
3/31/2024 | $ 6.07M | 100% | $ 6.07M |
12/31/2023 | $ 6.88M | 100% | $ 6.88M |
9/30/2023 | $ 4.37M | 100% | $ 4.37M |
6/30/2023 | $ 3.25M | 100% | $ 3.25M |
3/31/2023 | $ 3.15M | 100% | $ 3.15M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for CELLDEX THERAPEUTICS INC is calculated as follows: GP [ $ 4.52M ] / Revenues [ $ 4.52M ]
(=) Gross % [ 100% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.09% |
median | 49.46% |
std | 31.59% |